Although the formal criterion for stopping the trial was not met , the Data and Safety Monitoring Committee recommended study termination on ethical grounds based on the interaction ( two-sided P = @ , hazard ratios for @/@ : @ / @ ) between age and subgroup and treatment arm , which suggested that docetaxel may not represent an adequate control arm regimen for the age subgroup of @-@ years .